Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Bay-12-8039: time-kill and PAE studies

June 13, 1997

Activity of Sch-48973 against enteroviruses

June 13, 1997

D-0870 for AIDS-related oral candidiasis

June 13, 1997

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

New antibacterial agents described by Zeneca

June 10, 1997

Generic aciclovir approved by FDA

June 9, 1997

In vitro activity of MEN-10700 assessed

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...